Trident Lifeline Limited
Latest filings
- Q2 FY27 growth accelerates; management targets threefold business in three years · Investor Communications
- Quarter to Sep 2026: consolidated revenue up 50%, after-tax profit up 30% year on year; revised · Results
- Q2 FY27 revenue rises 50%, profit after tax rises 30% · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Sells a wide pharmaceutical product portfolio of 3,625 products, with 1,091 products registered across 46 countries and 2,534 registrations pending, generating revenue from both domestic and export markets. In FY26, consolidated revenue was Rs 129.02 crore, up 48.4% year-on-year, driven by growth in pharmaceutical sales. The company also operates a medical-device subsidiary, Trident Mediquip Limited (TML), in which it holds around 58.67% and which reported turnover of Rs 27.31 crore in FY26 versus Rs 21.29 crore in FY25. Materials are the single largest cost at 46.5% of revenue, followed by other operating expenses at 10.6% and employee costs at 8.4%. Capital expenditure absorbed 28.3% of revenue in FY26, reflecting ongoing investment in the business. The company is currently migrating its listing from the BSE SME platform to the BSE and NSE main boards.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from Trident Lifeline Limited's filed financials and exchange disclosures
What does Trident Lifeline Limited do?
Trident Lifeline Limited is a Pharmaceuticals & Biotechnology company listed on BSE.
Is Trident Lifeline Limited expensive compared with its peers?
On trailing P/E, Trident Lifeline Limited ranks 36 of 160 in Pharmaceuticals — cheaper than 78% of them, against an industry median of 29.2×. This is a position, not a valuation judgement.
How much does the Trident Lifeline Limited share price move in a day?
On a typical session Trident Lifeline Limited moves 1.32% — that is the median absolute close-to-close move across its last 258 trading days. MarketPing measures each filing's price reaction against it.
Where can I track Trident Lifeline Limited's announcements?
Every NSE and BSE filing by Trident Lifeline Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.